Hepatitis C and risky business
IN 2013 approximately 230,000 people were living in Australia with chronic hepatitis C infection (HCV). Although most of these infections are early-stage disease, 80,000 people suffer moderate to severe liver disease.
While the diagnosis rates have declined over the past decade to the current estimated population prevalence of approximately 1.4%, hepatitis C still remains a concern. 1
The transmission of hepatitis C is predominantly parenteral via exposure to blood and blood products. Considering transmission efficiency, it is not surprising that people who inject drugs account for the large